Fibrocell Science, Inc. (NASDAQ:FCSC) went up to recover about 88.24% since recording its record low price of $0.51. The stock experienced 60.43% jump, arriving at $0.96 on 05/17/2018. During the day, the stock price traveled from $0.69 to $0.97. This company shares are 368.75% off its target price of $4.5 and the current market capitalization stands at $27.25M. The recent change has given its price a 59.59% lead over SMA 50 and -79.29% deficit over its 52-week high. The stock witnessed 51.16% gains, 44.38% gains and -45.14% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found FCSC’s volatility during a week at 13.78% and during a month it has been found around 8%.Fibrocell Science, Inc. (FCSC) Top Holders
Institutional investors currently hold around $6 million or 43.9% in FCSC stock. Look at its top three institutional owners. Third Security, Llc owns $4.94 million in Fibrocell Science, Inc., which represents roughly 18.14% of the company’s market cap and approximately 82.4% of the institutional ownership. Similar statistics are true for the second largest owner, Msd Partners, L.P., which owns 692,960 shares of the stock are valued at $414 thousand. The third largest holder is Point72 Asset Management, L.P., which currently holds $239 thousand worth of this stock and that ownership represents nearly 0.88% of its market capitalization.
At the end of 03/31/2018 reporting period, 12 institutional holders increased their position in Fibrocell Science, Inc. (NASDAQ:FCSC) by some 491,525 shares, 13 decreased positions by 2,470,681 and 12 held positions by 7,656,814. That puts total institutional holdings at 10,619,020 shares, according to SEC filings. The stock grabbed 5 new institutional investments totaling 144,069 shares while 6 institutional investors sold out their entire positions totaling 2,247,463 shares.Fibrocell Science, Inc. (NASDAQ:FCSC) Insider Trades
Multiple company employees have indulged in significant insider trading. Fibrocell Science, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that 10% Owner Kirk Randal J has acquired 2,727,273 shares of Fibrocell Science, Inc. (FCSC) in trading session dated Dec. 11, 2017. These shares are worth $2,100,000 and were traded at $0.77 each. The SEC filing shows that Pernock David performed a purchase of 16,667 shares. The Chairman and CEO added these shares by way of transaction on Dec. 02, 2016. The company’s shares were assimilated at $2.76 per share worth to an investment of some $46,001 on account of Pernock David.
Chairman and CEO, Pernock David, purchased 1,000 common shares of Fibrocell Science, Inc. (FCSC) in the open market. In a transaction dated Nov. 13, 2015, the shares were bought at an average price of $15, giving away a sum of $15,000. After this purchase, 18,533 common shares of FCSC are directly owned by the insider, with total stake valued at $17,792.
In the transaction dated Aug. 11, 2015, the great number of shares acquired came courtesy the Chairman and CEO; Pernock David added a total of 1,167 shares at an average price of $19.62, amounting to approximately $22,897. The insider now directly owns 17,533 shares worth $16,832.Fibrocell Science, Inc. (FCSC) Analyst Guide
Not many analysts have released their opinion on Fibrocell Science, Inc. (NASDAQ:FCSC), with 2 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1 average brokerage recommendation.